181 related articles for article (PubMed ID: 22465882)
1. Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice.
Porter D; Faivre E; Flatt PR; Hölscher C; Gault VA
Peptides; 2012 May; 35(1):1-8. PubMed ID: 22465882
[TBL] [Abstract][Full Text] [Related]
2. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
Porter DW; Kerr BD; Flatt PR; Holscher C; Gault VA
Diabetes Obes Metab; 2010 Oct; 12(10):891-9. PubMed ID: 20920042
[TBL] [Abstract][Full Text] [Related]
3. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet.
Gault VA; Porter WD; Flatt PR; Hölscher C
Int J Obes (Lond); 2010 Aug; 34(8):1341-4. PubMed ID: 20351729
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
Porter WD; Flatt PR; Hölscher C; Gault VA
Int J Obes (Lond); 2013 May; 37(5):678-84. PubMed ID: 22665137
[TBL] [Abstract][Full Text] [Related]
5. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice.
Porter DW; Irwin N; Flatt PR; Hölscher C; Gault VA
Eur J Pharmacol; 2011 Jan; 650(2-3):688-93. PubMed ID: 21050845
[TBL] [Abstract][Full Text] [Related]
6. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
[TBL] [Abstract][Full Text] [Related]
7. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
Gault VA; Kerr BD; Harriott P; Flatt PR
Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446
[TBL] [Abstract][Full Text] [Related]
8. Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice.
Sridhar A; Khan D; Babu G; Irwin N; Gault VA; Flatt PR; Moffett CR
Peptides; 2024 Aug; 178():171254. PubMed ID: 38815655
[TBL] [Abstract][Full Text] [Related]
9. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
Irwin N; Hunter K; Montgomery IA; Flatt PR
Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats.
Freyse EJ; Berg S; Kohnert KD; Heinke P; Salzsieder E
Biol Chem; 2011 Mar; 392(3):209-15. PubMed ID: 21281062
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice.
Lennox R; Porter DW; Flatt PR; Holscher C; Irwin N; Gault VA
Neuropharmacology; 2014 Nov; 86():22-30. PubMed ID: 24998752
[TBL] [Abstract][Full Text] [Related]
12. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
[TBL] [Abstract][Full Text] [Related]
13. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed mice.
Irwin N; Montgomery IA; Flatt PR
Br J Nutr; 2012 Jul; 108(1):46-56. PubMed ID: 22260799
[TBL] [Abstract][Full Text] [Related]
15. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential.
Pathak NM; Pathak V; Gault VA; McClean S; Irwin N; Flatt PR
Biochem Pharmacol; 2018 Sep; 155():264-274. PubMed ID: 30028989
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
Green BD; Gault VA; O'Harte FP; Flatt PR
Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
[TBL] [Abstract][Full Text] [Related]
17. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
18. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice.
Faivre E; Hamilton A; Hölscher C
Eur J Pharmacol; 2012 Jan; 674(2-3):294-306. PubMed ID: 22115896
[TBL] [Abstract][Full Text] [Related]
20. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]